Publications
5810 Results
- Journal / Conference
- Arch Osteoporos. 2019 Jul 28;14(1):83
- Year
- 2019
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID31352608
- PMC
- PMC6852789
- Study Number(s)
- SWOG-9304 (INT-0144), SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415), SWOG-9420
Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims
- Journal / Conference
- Blood Oct 10;134(15):1238-1246; Jul 22. pii: blood.2019000719. doi: 10.1182/blood.2019000719. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Lymphoma
- PMID
- PMID31331918
- PMC
- PMC6788007
- Study Number(s)
- S0816
Long-term Follow-up of SWOG S0816: Response-Adapted Therapy for Stage III/IV Hodgkin Lymphoma Demonstrates Limitations of PET-adapted Approach
- Journal / Conference
- JAMA Oncol. 2019 Jul 1;5(7):932-34. [viewpoint]
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID31169875
Reimbursing Patients for Participation in Cancer Clinical Trials
- Journal / Conference
- New England Journal of Medicine 2019 May 16;380(20):e38. doi: 10.1056/NEJMc1902700
- Year
- 2019
- Research Committee(s)
- Cancer Control
- PMID
- PMID31091400
- Study Number(s)
- SWOG-9217
More on Long-Term Effects of Finasteride on Prostate Cancer Mortality [reply to letter to editor]
- Journal / Conference
- Clinical Cancer Research Oct 15;25(20):6089-6097; Jul 29 Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Breast
- PMID
- PMID31358544
- PMC
- PMC6801082
- Study Number(s)
- S0500
Circulating Tumor Cell Clusters in Metastatic Breast Cancer Patients: a SWOG S0500 Translational Medicine Study
- Journal / Conference
- BMC Medical Research Methodology Jun 11;19(1):119
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID31185918
- PMC
- PMC6560751
- Study Number(s)
- S1415CD
Effective Stakeholder Engagement: Design and Implementation of a Clinical Trial (SWOG S1415CD) to Improve Cancer Care
- Journal / Conference
- New England Journal of Medicine Jun 20;380(25):2395-2405
- Year
- 2019
- Research Committee(s)
- Breast
- PMID
- PMID31157962
- PMC
- PMC6709671
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
- Journal / Conference
- European Urology Feb;75(2):240-241
- Year
- 2019
- Research Committee(s)
- Genitourinary
- PMID
- PMID30366635
- Study Number(s)
- S1314
ERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder Cancers [Editorial]
- Journal / Conference
- European Urology Focus Nov;5(6):927-929; May 15 [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Genitourinary
- PMID
- PMID31103605
- PMC
- PMC6858992
- Study Number(s)
- SWOG-8949
Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
- Journal / Conference
- Urologic Oncology May;37(5):313-317
- Year
- 2019
- Research Committee(s)
- Genitourinary
- PMID
- PMID30115512
- PMC
- PMC6886001